Stimulus-responsive controlled release system by covalent immobilization of an enzyme into mesoporous silica nanoparticles

Bioconjugate Chemistry

Volumn 23, Issue 4, 2012, Pages 698-704

  Méndez, Jessica ^a   Monteagudo, Alina ^a   Griebenow, Kai ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; CARBONIC ANHYDRASE; CONTROLLED DRUG DELIVERY; ENZYME ACTIVITY; ENZYME IMMOBILIZATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; LANTHANUM COMPOUNDS; LIGHT SCATTERING; SILICA NANOPARTICLES; SULFUR COMPOUNDS; TARGETED DRUG DELIVERY; X RAY PHOTOELECTRON SPECTROSCOPY;

CONTROLLED RELEASE SYSTEMS; COVALENT IMMOBILIZATION; DRUG DELIVERY CARRIER; FUNCTIONALIZED; GLUTHATHIONE; MESOPOROUS SILICA NANOPARTICLES; REDOX CONDITION; STIMULI-RESPONSIVE; THERAPEUTIC AGENTS; THIOL GROUPS;

PEPTIDES;

CARBONATE DEHYDRATASE; DISULFIDE; GLUTATHIONE; MESOPOROUS SILICA NANOPARTICLE; NANOPARTICLE; REDOX EFFECTOR FACTOR 1; SILICON DIOXIDE; STAUROSPORINE; THIOL; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; CONTROLLED STUDY; COVALENT BOND; DRUG DELIVERY SYSTEM; ENZYME IMMOBILIZATION; ENZYME INACTIVATION; HELA CELL; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; LIGHT SCATTERING; STIMULUS; X RAY PHOTOELECTRON SPECTROSCOPY;

EID: 84859981818     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200301a     Document Type: Article

References (41)

1. Ravichandran, R. (2009) Nanotechnology-based drug delivery systems. NanoBioTechnology 5, 17-33.
2. Bulmus, V., Woodward, M., Lin, L., Murthy, N., Stayton, P., and Hoffman, A. (2003) A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs. J. Controlled Release 93, 105-120. (Pubitemid 37421353)
3. Salonen, J., Kaukonen, A. M., Hirvonen, J., and Lehto, V. P. (2008) Mesoporous silicon in drug delivery applications. J. Pharm. Sci. 97, 632-53. (Pubitemid 351293873)
4. You, Y. Z., Hong, C. Y., and Pan, C. Y. (2007) Covalently immobilizing a biological molecule onto a carbon nanotube via a stimuli-sensitive bond. J. Phys. Chem. C 111, 16161-16166.
5. Harris, J. M., and Chess, R. B. (2003) Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discovery 2, 214-221.
6. Cho, K., Wang, X., and Nie, S. (2008) Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 14, 1310-1316. (Pubitemid 351413909)
7. Kairemo, K., Erba, P., Bergström, K., and Pauwels, E. K. J. (2008) Nanoparticles in cancer. Curr. Radiopharm. 1, 30-36.
8. Radu, D. R., Lai, C. Y., Jeftinija, K., Rowe, E. W., Jeftinija, S., and Lin, V. S. Y. (2004) A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J. Am. Chem. Soc. 126, 13216-13217. (Pubitemid 39382736)
9. Vivero-Escoto, J. L., Slowing, I. I., Wu, C. W., and Lin, V. S. Y. (2009) Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. J. Am. Chem. Soc. 131, 3462.
10. Zhu, Y. C., Liu, H. J., Li, F., Ruan, Q. C., Wang, H., Fujiwara, M., Wang, L. Z., and Lu, G. Q. (2010) Dipolar molecules as impellers achieving electric-field-stimulated release. J. Am. Chem. Soc. 132, 1450-1451.
11. Zhao, Y. L., Li, Z. X., Kabehie, S., Botros, Y. Y., Stoddart, J. F., and Zink, J. I. (2010) pH-operated nanopistons on the surfaces of mesoporous silica nanoparticles. J. Am. Chem. Soc. 132, 13016-13025.
12. Liu, R., Zhao, X., Wu, T., and Feng, P. Y. (2008) Tunable redox-responsive hybrid nanogated ensembles. J. Am. Chem. Soc. 130, 14418-14419.
13. Trewyn, B. G., Giri, S., Slowing, I. I., and Lin, V. S. Y. (2007) Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. Chem. Commun., 3236-3245. (Pubitemid 47197838)
14. Kam, N. W. S., Liu, Z., and Dai, H. J. (2005) Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J. Am. Chem. Soc. 127, 12492-12493. (Pubitemid 41292159)
15. Luo, Z., Cai, K. Y., Hu, Y., Zhao, L., Liu, P., Duan, L., and Yang, W. H. (2011) Mesoporous silica nanoparticles end-capped with collagen: redox-responsive nanoreservoirs for targeted drug delivery. Angew. Chem. 50, 640-643.
16. Hong, R., Han, G., Fernandez, J. M., Kim, B. J., Forbes, N. S., and Rotello, V. M. (2006) Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. J. Am. Chem. Soc. 128, 1078-1079. (Pubitemid 43190611)
17. Ganta, S., Devalapally, H., Shahiwala, A., and Amiji, M. (2008) A review of stimuli-responsive nanocarriers for drug and gene delivery. J. Controlled Release 126, 187-204.
18. Meister, A., and Anderson, M. E. (1983) Glutathione. Annu. Rev. Biochem. 52, 711-760. (Pubitemid 13030692)
19. Lin, W. S., Huang, Y. W., Zhou, X. D., and Ma, Y. F. (2006) In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol. Appl. Pharmacol. 217, 252-259.
20. Yu, K. O., Grabinski, C. M., Schrand, A. M., Murdock, R. C., Wang, W., Gu, B. H., Schlager, J. J., and Hussain, S. M. (2009) Toxicity of amorphous silica nanoparticles in mouse keratinocytes. J. Nanoparticle Res. 11, 15-24.
21. Slowing, I. I., Trewyn, B. G., and Lin, V. S. Y. (2007) Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J. Am. Chem. Soc. 129, 8845-8849. (Pubitemid 47492073)
22. Chung, T. H., Wu, S. H., Yao, M., Lu, C. W., Lin, Y. S., Hung, Y., Mou, C. Y., Chen, Y. C., and Huang, D. M. (2007) The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 28, 2959-2966. (Pubitemid 46560868)
23. Lu, J., Liong, M., Zink, J. I., and Tamanoi, F. (2007) Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 3, 1341-1346. (Pubitemid 47245524)
24. Slowing, I., Trewyn, B. G., and Lin, V. S. Y. (2006) Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticleson the endocytosis by human cancer cells. J. Am. Chem. Soc. 128, 14792-14793. (Pubitemid 44851603)
25. Lin, Y. S., Tsai, C. P., Huang, H. Y., Kuo, C. T., Hung, Y., Huang, D. M., Chen, Y. C., and Mou, C. Y. (2005) Well-ordered mesoporous silica nanoparticles as cell markers. Chem. Mater. 17, 4570-4573. (Pubitemid 41362484)
26. Huang, D. M., Hung, Y., Ko, B. S., Hsu, S. C., Chen, W. H., Chien, C. L., Tsai, C. P., Kuo, C. T., Kang, J. C., Yang, C. S., Mou, C. Y., and Chen, Y. C. (2005) Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking. FASEB J. 19, 2014-2016. (Pubitemid 41759749)
27. Krishnamurthy, V. M., Kaufman, G. K., Urbach, A. R., Gitlin, I., Gudiksen, K. L., Weibel, D. B., and Whitesides, G. M. (2008) Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding. Chem. Rev. 108, 946-1051. (Pubitemid 351577855)
28. Saito, R., Sato, T., Ikai, A., and Tanaka, N. (2004) Structure of bovine carbonic anhydrase II at 1.95 angstrom resolution. Acta Crystallogr., Sect. D 60, 792-795. (Pubitemid 41184850)
29. Lindskog, S. (1997) Structure and mechanism of carbonic anhydrase. Pharmacol. Ther. 74, 1-20.
30. 2 sequestration: 1. Immobilization of carbonic anhydrase within polyurethane foam. Energy Fuels 23, 5725-5730.
31. Montalvo, B. L., Pacheco, Y., Sosa, B. A., Velez, D., Sanchez, G., and Griebenow, K. (2008) Formation of spherical protein nanoparticles without impacting protein integrity. Nanotechnology 19, 465103.
32. Barltrop, J. A., Owen, T. C., Cory, A. H., and Cory, J. G. (1991) 5-(3-Carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl) tetrazolium, inner salt (Mts) and related analogs of 3-(4,5-dimethylthiazolyl)- 2,5-diphenyltetrazolium bromide (Mtt) reducing to purple water-soluble formazans as cell-viability indicators. Bioorg. Med. Chem. Lett. 1, 611.
33. Cory, A. H., Owen, T. C., Barltrop, J. A., and Cory, J. G. (1991) Use of an aqueous soluble tetrazolium formazan assay for cell-growth assays in culture. Cancer Commun. 3, 207-212.
34. Qu, X., and Qing, L. (2004) Abrin induces HeLa cell apoptosis by cytochrome c release and caspase activation. Biochem. Mol. Biol. 37, 445-453. (Pubitemid 39207678)
35. Stevens, R., Stevens, L., and Price, N. C. (1983) The stabilities of various compounds used in protein purifications. Biochem Educ 11, 70.
36. Hernández-Padrón, G., Rodríguez, R., and Castañro, V. M. (2005) In-situ thiol-modified silica nanoparticles. Int. J. Nanotechnol., 1.
37. Carlsson, J., Drevin, H., and Axen, R. (1978) Protein thiolation and reversible protein-protein conjugation. N-succinimidyl 3-(2-pyridyldithio) propionate, a new heterobifunctional reagent. Biochem. J. 173, 723-37. (Pubitemid 9010965)
38. Habeeb, A. F. (1966) Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal. Biochem. 14, 328-36.
39. Mortera, R., Vivero-Escoto, J., Slowing, I. I., Garrone, E., Onida, B., and Lin, V. S.-Y. (2009) Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticles-based drug delivery system. Chem. Commun., 3219-3221.
40. Wei, X. L., Sun, N. Y., Wu, B. J., Yin, C. H., and Wu, W. (2006) Sigmoidal release of indomethacin from pectin matrix tablets: effect of in situ crosslinking by calcium cations. Int. J. Pharm. 318, 132-138.
41. Liong, M., Lu, J., Kovochich, M., Xia, T., Ruehm, S. G., Nel, A. E., Tamanoi, F., and Zink, J. I. (2008) Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2, 889-896.